Kathleen M Schmainda

12PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyInstruments and techniquesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 06, 2026
Fractional tumor burden refines prognostic stratification beyond MGMT status in glioblastoma after chemoradiotherapy.

|Dec 10, 2024
The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing Gliomas.

Mark S Shiroishi, Bradley J Erickson, Leland S Hu

|Oct 10, 2024
Multisite Benchmark Study for Standardized Relative CBV in Untreated Brain Metastases Using the DSC-MRI Consensus Acquisition Protocol.

Sarah Kohn Loizzo, Melissa A Prah, Min J Kong

|Aug 21, 2024
Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor at Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma.

Louis Gagnon, Diviya Gupta, George Mastorakos

|May 23, 2024
Identification of a Single-Dose, Low-Flip-Angle-Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma.

Aliya Anil, Ashley M Stokes, John P Karis

|Mar 14, 2020
Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies.

J M Hoxworth, J M Eschbacher, A C Gonzales

Pageof 2

Frequent Collaborators

6 joint publications

Melissa A Prah

6 joint publications

C Chad Quarles

6 joint publications

Leland S Hu

5 joint publications

Jerrold L Boxerman